MYD88 L265P in Waldenström macroglobulinemia, immunoglobulin M monoclonal gammopathy, and other B-cell lymphoproliferative disorders using conventional and quantitative allele-specific polymerase chain reaction
Top Cited Papers
Open Access
- 14 March 2013
- journal article
- Published by American Society of Hematology in Blood
- Vol. 121 (11), 2051-2058
- https://doi.org/10.1182/blood-2012-09-454355
Abstract
Key Points MYD88 L265P is expressed in WM and IgM MGUS patients using AS-PCR assays with potential use in diagnostic discrimination and response assessment.Keywords
This publication has 25 references indexed in Scilit:
- MYD88 L265P Mutation in Waldenstrom's MacroglogulinemiaBlood, 2012
- IGHV gene features and MYD88 L265P mutation separate the three marginal zone lymphoma entities and Waldenström macroglobulinemia/lymphoplasmacytic lymphomasLeukemia, 2012
- MYD88 L265P Somatic Mutation in Waldenström's MacroglobulinemiaThe New England Journal of Medicine, 2012
- Activating L265P mutations of the MYD88 gene are common in primary central nervous system lymphomaActa Neuropathologica, 2011
- Analysis of the coding genome of diffuse large B-cell lymphomaNature Genetics, 2011
- Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemiaNature, 2011
- Oncogenically active MYD88 mutations in human lymphomaNature, 2010
- Helical assembly in the MyD88–IRAK4–IRAK2 complex in TLR/IL-1R signallingNature, 2010
- Identification of Critical Residues of the MyD88 Death Domain Involved in the Recruitment of Downstream KinasesOnline Journal of Public Health Informatics, 2009
- Clinicopathological definition of Waldenstrom's macroglobulinemia: Consensus Panel Recommendations from the Second International Workshop on Waldenstrom's MacroglobulinemiaSeminars in Oncology, 2003